{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:32:31Z","timestamp":1793403151850,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100015080","name":"Rafael del Pino Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015080","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC\/TRR 205\/1"],"award-info":[{"award-number":["CRC\/TRR 205\/1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jid.2021.12.028","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T16:27:46Z","timestamp":1641227266000},"page":"2217-2227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Therapeutic Potential of Nitric Oxide\u2012Releasing Selective Estrogen Receptor Modulators in Malignant Melanoma"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6932-333X","authenticated-orcid":false,"given":"Nicole","family":"Bechmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6922-9415","authenticated-orcid":false,"given":"Bruna","family":"Calsina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3549-2477","authenticated-orcid":false,"given":"Susan","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1610-1493","authenticated-orcid":false,"given":"Jens","family":"Pietzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2021.12.028_bib1","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1158\/0008-5472.CAN-06-3481","article-title":"A\u00a0high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis","volume":"67","author":"Alonso","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2021.12.028_bib2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.mce.2015.01.016","article-title":"Estrogen receptor alpha phosphorylation and its functional impact in human breast cancer","volume":"418","author":"Anbalagan","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jid.2021.12.028_bib3","doi-asserted-by":"crossref","first-page":"15840","DOI":"10.1038\/ncomms15840","article-title":"Insufficient antibody validation challenges oestrogen receptor beta research [published correction in Nat Commun 2017;8:16164]","volume":"8","author":"Andersson","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2021.12.028_bib4","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2021.12.028_bib5","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3390\/md16050172","article-title":"Anti-tumorigenic and anti-metastatic activity of the sponge-derived marine drugs aeroplysinin-1 and isofistularin-3 against pheochromocytoma in\u00a0vitro","volume":"16","author":"Bechmann","year":"2018","journal-title":"Mar Drugs"},{"key":"10.1016\/j.jid.2021.12.028_bib6","first-page":"1010","article-title":"Nitric oxide-releasing selective cyclooxygenase-2 inhibitors as promising radiosensitizers in melanoma cells in\u00a0vitro","volume":"1","author":"Bechmann","year":"2017","journal-title":"Ann Radiat Ther Oncol"},{"key":"10.1016\/j.jid.2021.12.028_bib7","doi-asserted-by":"crossref","first-page":"6525","DOI":"10.1021\/acs.jmedchem.9b00171","article-title":"Nitric oxide-releasing selective estrogen receptor modulators: a bifunctional approach to improve the therapeutic index","volume":"62","author":"Bechmann","year":"2019","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.jid.2021.12.028_bib8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1530\/ERC-20-0205","article-title":"HIF2\u03b1 supports pro-metastatic behavior in pheochromocytomas\/paragangliomas","volume":"27","author":"Bechmann","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jid.2021.12.028_bib9","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1210\/me.2004-0486","article-title":"Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes","volume":"19","author":"Bj\u00f6rnstr\u00f6m","year":"2005","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jid.2021.12.028_bib10","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/jdv.12972","article-title":"Increased mortality for pregnancy-associated melanoma: systematic review and meta-analysis","volume":"29","author":"Byrom","year":"2015","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2021.12.028_bib11","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jid.2021.12.028_bib12","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1038\/sj.onc.1205420","article-title":"Phosphorylation of human estrogen receptor \u03b1 at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera","volume":"21","author":"Chen","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2021.12.028_bib13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1172\/JCI5347","article-title":"Estrogen receptor \u03b1 mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen [published correction in J Clin Invest 1999;103:1363]","volume":"103","author":"Chen","year":"1999","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2021.12.028_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2014.07.014","article-title":"Nitric oxide in cancer metastasis","volume":"353","author":"Cheng","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jid.2021.12.028_bib15","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1056\/NEJM199208203270803","article-title":"Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen","volume":"327","author":"Cocconi","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2021.12.028_bib16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/bjd.12056","article-title":"Oestrogen receptor beta and melanoma: a comparative study","volume":"168","author":"De Giorgi","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2021.12.028_bib17","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1586\/era.11.42","article-title":"Estrogens, estrogen receptors and melanoma","volume":"11","author":"De Giorgi","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.jid.2021.12.028_bib18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/archdermatol.2008.537","article-title":"Estrogen receptor expression in cutaneous melanoma: a real-time reverse transcriptase\u2013polymerase chain reaction and immunohistochemical study","volume":"145","author":"De Giorgi","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2021.12.028_bib19","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.3390\/cancers11101418","article-title":"Estrogen receptors in epithelial-mesenchymal transition of prostate cancer","volume":"11","author":"Di Zazzo","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jid.2021.12.028_bib20","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3390\/cells8111463","article-title":"Estrogen receptors and melanoma: a review","volume":"8","author":"Dika","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jid.2021.12.028_bib21","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/jdv.14304","article-title":"Expression of G protein-coupled oestrogen receptor in melanoma and in pregnancy-associated melanoma","volume":"31","author":"F\u00e1bi\u00e1n","year":"2017","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2021.12.028_bib22","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1245\/s10434-018-6513-7","article-title":"Melanoma staging: American Joint Committee on Cancer (AJCC) 8th edition and beyond [published correction in Ann Surg Oncol 2018;25:993\u20124]","volume":"25","author":"Gershenwald","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jid.2021.12.028_bib23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0006-291X(03)00546-1","article-title":"Nitric oxide disrupts VE-cadherin complex in murine microvascular endothelial cells","volume":"304","author":"Gonz\u00e1lez","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jid.2021.12.028_bib24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1479-5876-12-16","article-title":"The therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumors","volume":"12","author":"Gu","year":"2014","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.jid.2021.12.028_bib25","doi-asserted-by":"crossref","first-page":"7857","DOI":"10.1038\/srep07857","article-title":"Cancer systems biology of TCGA SKCM: efficient detection of genomic drivers in melanoma","volume":"5","author":"Guan","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2021.12.028_bib26","first-page":"302","article-title":"Is oestrogen an important player in melanoma progression?","volume":"18","author":"Janik","year":"2014","journal-title":"Contemp Oncol (Pozn)"},{"key":"10.1016\/j.jid.2021.12.028_bib27","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1200\/JCO.2012.44.5031","article-title":"Sex is an independent prognostic indicator for survival and relapse\/progression-free survival in metastasized stage III to IV melanoma: a pooled analysis of five European Organisation for Research and Treatment of Cancer randomized controlled trials","volume":"31","author":"Joosse","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2021.12.028_bib28","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/jid.2010.354","article-title":"Gender differences in melanoma survival: female patients have a decreased risk of metastasis","volume":"131","author":"Joosse","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.12.028_bib29","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrc2048","article-title":"Chemoprevention of breast cancer with selective oestrogen-receptor modulators","volume":"7","author":"Jordan","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jid.2021.12.028_bib30","first-page":"812540","article-title":"The dynamic structure of the estrogen receptor","volume":"2011","author":"Kumar","year":"2011","journal-title":"J\u00a0Amino Acids"},{"key":"10.1016\/j.jid.2021.12.028_bib31","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/bjd.12426","article-title":"E-to N-cadherin switch in melanoma is associated with decreased expression of phosphatase and tensin homolog and cancer progression","volume":"169","author":"Lade-Keller","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2021.12.028_bib32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00008390-199510000-00010","article-title":"Dacarbazine, cisplatin and carmustine, with or without tamoxifen, for metastatic melanoma: 5-year follow-up","volume":"5","author":"Lattanzi","year":"1995","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jid.2021.12.028_bib33","doi-asserted-by":"crossref","first-page":"13162","DOI":"10.1073\/pnas.0605676103","article-title":"Estrogen receptor (ER)-\u03b2 isoforms: a key to understanding ER-\u03b2 signaling [published correction in Proc Natl Acad USA 2006;103:14977]","volume":"103","author":"Leung","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2021.12.028_bib34","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3389\/fendo.2020.00184","article-title":"Estrogen receptors promote migration, invasion and colony formation of the androgen-independent prostate cancer cells PC-3 through \u03b2-catenin pathway","volume":"11","author":"Lombardi","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jid.2021.12.028_bib35","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fendo.2016.00140","article-title":"Estrogen receptor \u03b2 in melanoma: from molecular insights to potential clinical utility","volume":"7","author":"Marzagalli","year":"2016","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jid.2021.12.028_bib36","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.mce.2012.08.016","article-title":"Estrogens promote cell\u2013cell adhesion of normal and malignant mammary cells through increased desmosome formation","volume":"364","author":"Maynadier","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jid.2021.12.028_bib37","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/978-0-387-69080-3_48","article-title":"Role of estrogens and their receptors in adhesion and invasiveness of breast cancer cells","volume":"617","author":"Maynadier","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jid.2021.12.028_bib38","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/CMR.0b013e32834577c8","article-title":"Sex differences in survival of cutaneous melanoma are age dependent: an analysis of 7338 patients","volume":"21","author":"Mervic","year":"2011","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jid.2021.12.028_bib39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s40487-020-00109-1","article-title":"Gender differences and outcomes in melanoma patients","volume":"8","author":"Morgese","year":"2020","journal-title":"Oncol Ther"},{"key":"10.1016\/j.jid.2021.12.028_bib40","doi-asserted-by":"crossref","first-page":"e31770","DOI":"10.7554\/eLife.31770","article-title":"Activation of G protein-coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade","volume":"7","author":"Natale","year":"2018","journal-title":"ELife"},{"key":"10.1016\/j.jid.2021.12.028_bib41","doi-asserted-by":"crossref","first-page":"851387","DOI":"10.1155\/2015\/851387","article-title":"Novel approaches to treatment of advanced melanoma: a review on targeted therapy and immunotherapy","volume":"2015","author":"Niezgoda","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jid.2021.12.028_bib42","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1292\/jvms.09-0573","article-title":"Nitric oxide causes anoikis through attenuation of E-cadherin and activation of caspase-3 in human gastric carcinoma AZ-521 cells infected with Mycoplasma hyorhinis","volume":"72","author":"Obara","year":"2010","journal-title":"J\u00a0Vet Med Sci"},{"key":"10.1016\/j.jid.2021.12.028_bib43","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1346-8138.2008.00447.x","article-title":"Expression of estrogen receptor beta in normal skin, melanocytic nevi and malignant melanomas","volume":"35","author":"Ohata","year":"2008","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jid.2021.12.028_bib44","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/1523-1747.ep12317599","article-title":"Tamoxifen and quercetin interact with type II estrogen binding sites and inhibit the growth of human melanoma cells","volume":"105","author":"Piantelli","year":"1995","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.12.028_bib45","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nrendo.2011.122","article-title":"The G-protein-coupled estrogen receptor GPER in health and disease","volume":"7","author":"Prossnitz","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jid.2021.12.028_bib46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/2277-9175.200789","article-title":"Expression of estrogen receptor alpha in malignant melanoma","volume":"6","author":"Rajabi","year":"2017","journal-title":"Adv Biomed Res"},{"key":"10.1016\/j.jid.2021.12.028_bib47","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/CMR.0b013e32835e58f3","article-title":"Experimental hypoxia does not influence gene expression and protein synthesis of Eph receptors and ephrin ligands in human melanoma cells in\u00a0vitro","volume":"23","author":"Reissenweber","year":"2013","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jid.2021.12.028_bib48","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1172\/JCI119426","article-title":"Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. Gender difference and effect\u00a0of\u00a0estrogen receptor gene disruption","volume":"99","author":"Rubanyi","year":"1997","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2021.12.028_bib49","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1200\/JCO.1996.14.7.2083","article-title":"Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group","volume":"14","author":"Rusthoven","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2021.12.028_bib50","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1200\/JCO.2014.56.2736","article-title":"Pooled\u00a0analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma","volume":"33","author":"Schadendorf","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2021.12.028_bib51","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jid.2021.12.028_bib52","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1365-2133.1995.tb16942.x","article-title":"Increased thickness of pregnancy-associated melanoma","volume":"132","author":"Travers","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2021.12.028_bib53","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0303-7207(88)90072-X","article-title":"Estrogenic activity of phenol red","volume":"57","author":"Welshons","year":"1988","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jid.2021.12.028_bib54","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1158\/1078-0432.CCR-12-3039","article-title":"Lack of estrogen receptor-\u03b1 is associated with epithelial\u2013mesenchymal transition and PI3K alterations in endometrial carcinoma","volume":"19","author":"Wik","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2021.12.028_bib55","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/bies.20324","article-title":"Nitric oxide and metastatic cell behaviour","volume":"27","author":"Williams","year":"2005","journal-title":"Bioessays"},{"key":"10.1016\/j.jid.2021.12.028_bib56","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/DAD.0b013e3182914c64","article-title":"Immunohistochemical expression of hormone receptors in melanoma of pregnant women, nonpregnant women, and men","volume":"36","author":"Zhou","year":"2014","journal-title":"Am J Dermatopathol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X21026919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X21026919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:09:07Z","timestamp":1777417747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X21026919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":56,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0022202X21026919"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2021.12.028","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Potential of Nitric Oxide\u2012Releasing Selective Estrogen Receptor Modulators in Malignant Melanoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2021.12.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}